Stay updated on GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial
Sign up to get notified when there's something new on the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page.

Latest updates to the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.6.4 has been added and Revision: v3.6.3 has been removed from the page. This reflects a minor software version update in the site's release notes area.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, representing a minor update to the page's metadata. The study content and displayed information appear unchanged.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2. This indicates a newer system revision has been applied.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page now indicates that enrollment is closed, and it adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting update to the Intervention/Treatment label and removal of an older Revision tag.SummaryDifference0.2%

- Check57 days agoChange DetectedUpdated the page revision from v3.5.4 to v3.5.5, representing a minor platform or UI update rather than changes to study content.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page metadata shows a new revision label: v3.5.4, replacing v3.5.3, which indicates a small maintenance update rather than substantive content changes. This appears to be a backend or documentation update with no user-facing impact.SummaryDifference0.0%

Stay in the know with updates to GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK1349572 vs RAL in Integrase Inhibitor-Naive Adults Clinical Trial page.